Ohama H, Hiraoka A, Tada T, Hirooka M, et al. Potential role of Geriatric Nutritional Risk Index as a risk factor for immune-mediated adverse events during durvalumab plus tremelimumab therapy in unresectable hepatocellular carcinoma. J Gastroenterol 2025 Aug 20. doi: 10.1007/s00535-025-02290.
PMID: 40833596